Filtered By:
Specialty: Internal Medicine
Condition: Heart Attack

This page shows you your search results in order of date. This is page number 10.

Order by Relevance | Date

Total 557 results found since Jan 2013.

Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study
CONCLUSION: As first-line T2D treatment, initiators receiving SGLT-2i showed a similar risk for MI/stroke/mortality, lower risk for HHF/mortality and HHF, and a similar safety profile except for an increased risk for genital infections compared with those receiving metformin.PRIMARY FUNDING SOURCE: Brigham and Women's Hospital and Harvard Medical School.PMID:35605236 | DOI:10.7326/M21-4012
Source: Annals of Internal Medicine - May 23, 2022 Category: Internal Medicine Authors: HoJin Shin Sebastian Schneeweiss Robert J Glynn Elisabetta Patorno Source Type: research

Gastrointestinal and non-gastrointestinal complication rates associated with diagnostic esophagogastroduodenoscopy under sedation
Esophagogastroduodenoscopy (EGD) under sedation may result in gastrointestinal (GI) and non-GI complications. However, no previous studies have reported 30-day GI and non-GI complications after diagnostic EGD under sedation. We conducted a retrospective, observational study of 30-day GI and non-GI complication rates after outpatient diagnostic EGD under sedation in subjects ≥18 years between January 2012 and December 2017 based on a common data model database. Thirty-day complication rates were compared with EGD under sedation or not, type of sedation drugs (midazolam only vs midazolam/propofol) and age groups (18-6...
Source: Medicine - May 13, 2022 Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research

Outcomes of Patients With Type 2 Myocardial Infarction Complicating Acute Ischemic Stroke
To study the patient profiles and the prognostic impact of type 2 myocardial infarction (MI) on outcomes of acute ischemic stroke (AIS).
Source: Mayo Clinic Proceedings - April 26, 2022 Category: Internal Medicine Authors: Salik Nazir, Robert W. Ariss, Abdul Mannan Khan Minhas, Keerat Rai Ahuja, Hani Jneid, George V. Moukarbel Tags: Original Article Source Type: research

Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease : A Case-Crossover Study
CONCLUSION: From 2000 to 2018, the use of PDE5 inhibitors increased 20-fold among Danish patients with IHD who were taking nitrates. A statistically significant association between concomitant use of these medications and cardiovascular adverse events could not be identified.PRIMARY FUNDING SOURCE: Ib Mogens Kristiansens Almene Fond and Helsefonden.PMID:35436155 | DOI:10.7326/M21-3445
Source: Annals of Internal Medicine - April 18, 2022 Category: Internal Medicine Authors: Anders Holt Paul Blanche Aksel Karl Georg Jensen Nina Nouhravesh Deepthi Rajan Mads Hashiba Jensen Mohammed El-Sheikh Anne-Marie Schjerning Morten Schou Gunnar Gislason Christian Torp-Pedersen Patricia McGettigan Morten Lamberts Source Type: research

COVID-19 related thrombosis: A mini-review
CONCLUSIONS: Contemporary rapidly evolving evidence shows that COVID-19 associated thrombosis was a novel clinical entity, especially in severely ill COVID-19 patients. There are multiple society-driven guidelines only, but without any level 1 evidence for management regimen. The ideal dose for prophylaxis is not established and may vary depending on balance of bleeding and thrombosis risk. The risk of bleeding may be increased in patients in intensive care unit.PMID:35403487 | PMC:PMC9006089 | DOI:10.1177/02683555211052170
Source: Phlebology - April 11, 2022 Category: Internal Medicine Authors: Nicole M Cheng Yiu Che Chan Stephen W Cheng Source Type: research